Company intelligence / Profile preview
Shanghai Life Science Technology
Shanghai, Shanghai, Chinashlifestemcell.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai Life Science Technology is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies in the fields of gene and cell therapies. Its pipeline includes mesenchymal stem cell therapies for respiratory diseases such as idiopathic pulmonary fibrosis and interstitial lung disease at Phase 2 clinical stage, as well as preclinical CAR-T programs targeting solid tumors.
- Therapeutic areas
- PulmonologyOncology
- Modalities
- Mesenchymal stem cell therapyMonoclonal antibodyCAR-T cell therapyNatural killer cell therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Shanghai Life Science Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Life Science Technology.